• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Mallinckrodt

Mergers MA spinoff arrows merging arrows
Pharma

Mallinckrodt, Endo become Keenova following generics spinoff

Some three months after merging, Mallinckrodt and Endo have successfully spun off their combined sterile injectables and generics businesses.
Fraiser Kansteiner Nov 11, 2025 9:54am
A shot from Prime Time Endos branded Peyronies commercial

Endo builds on ‘Bent Carrot’ campaign for fresh Xiaflex push

Aug 12, 2025 12:59pm
merger MA combined company mergers  acquisitions business development

Troubled Mallinckrodt, Endo telegraph $6.7B merger plans

Mar 13, 2025 10:18am
Mallinckrodt

BMJ report digs into Mallinckrodt's opioid selling tactics

Jun 10, 2024 6:30pm
A gavel in the foreground with the scale of justice in the background

Mallinckrodt wins court go-ahead for 2nd bankruptcy

Oct 11, 2023 10:55am
Bankruptcy

After $1.7B opioid deal, Mallinckrodt readies 2nd bankruptcy bid

Aug 23, 2023 2:19pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings